N-[1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332167021 (In-Stock Building Blocks)
- IUPAC Name
- N-[1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]ethene-1-sulfonamide
- Mol formula
- C13H15N3O3S
- Mol weight
- 293 Da
- Catalog Number(s)
- BBLS21332167021, EN300-54825820, bbls21332167021
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.25
- Heavy atoms count
- 20
- Rotatable bond count
- 5
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.23
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of N-[1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]ethene-1-sulfonamide (C13H15N3O3S) - CSSB21332167021](/st/structure/200/206a1004fdd927941b381524f9bfd415/CC%2528CC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png "C13H15N3O3S")
- Zoom the structure
- CSSB21332167021
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 719.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 755.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 789.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 823.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 857.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,680.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,485.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 3,683.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[(1R)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB21332048415](/st/structure/200/63c573793ae84bd94dec502ed1eaf6fd/C%255BC%2540%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(1S)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB21332097262](/st/structure/200/58e976d7c50b8004cb0f2927910164d3/C%255BC%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]ethene-1-sulfonamide - CSSB21332053700](/st/structure/200/5e8f8d928d1ae47fd723572d57934c78/C%253DCS%2528%253DO%2529%2528%253DO%2529NCC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]prop-2-enamide - CSSB01789044815](/st/structure/200/1f9928971c8bb2d5d3a94c4d3dfab6e3/CC%2528CC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1%2529NC%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB21332053713](/st/structure/200/b56b611a5c0b20eb39d655e4af8e93a0/C%253DCS%2528%253DO%2529%2528%253DO%2529NCCC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]ethene-1-sulfonamide - CSSB21332124556](/st/structure/200/4bac37bb44ecfe626493c1a0954ed204/CC%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[2-(3-methyl-1,2,4-oxadiazol-5-yl)-1-phenylethyl]ethene-1-sulfonamide - CSSB21332109415](/st/structure/200/18461afad874b32dcf6bedcb0d93f118/CC1%253DNOC%2528CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C2%253DCC%253DCC%253DC2%2529%253DN1.png)
